Several studies demonstrated that TFF3 overexpression strongly correlated with poor prognosis in various tumors [26, 27], which indicated that TFF3 could be a potentially superior diagnostic marker or therapeutic target for cervical cancer. Here, TFF3 is linked to cervical cancer.